-
William H. RobinsonStanford Univ.USA
-
The Robinson laboratory investigates the role of EBV and other microbes in the pathogenesis of autoimmune disease, with a focus on systemic lupus, rheumatoid arthritis, and multiple sclerosis. His laboratory pioneered development of protein arrays and high-throughput sequencing approaches to identify the targets of antibody responses, investigate mechanisms underlying disease, and to develop novel therapeutic approaches. Using these technologies, his lab is defining key roles for EBV and other microbes in the initiation and progression of SLE, RA and MS.
Dr. Robinson co-founded the Stanford Human Immune Monitoring Center, serves on the editorial boards of several journals, and serves as the Treasurer and on the Board of Directors of the Federation of Clinical Immunology Societies. He is an inventor on 23 patent applications, and technologies developed in his Stanford and VA laboratories have been licensed to nine companies in the biotechnology industry. He was elected to the American Society for Clinical Investigation, the Henry Kunkel Society, and the Association of American Physicians. Dr. Robinson received his MD and PhD degrees from Stanford University, and completed his clinical training in internal medicine at UCSF.Research & Clinical FocusAutoimmunity
Epstein-Barr virus
Systemic lupus erythematosus
Rheumatoid arthritis
Multiple sclerosis
| Date | Time | Room | Session Title | Lecture Title |
|---|---|---|---|---|
| May 15 | 09:00-10:00 | Room 1 (3F) | Keynote Lecture 1 | Central Role for EBV in Systemic Lupus Erythematosus |
